Schmitt Industries Announces Third Quarter Fiscal 2015 Operating

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Schmitt Industries Announces Third Quarter Fiscal 2015 Operating Results

PORTLAND, Ore., April 3, 2015 (GLOBE NEWSWIRE) -- Schmitt Industries, Inc. (Nasdaq: SMIT ) today announced its operating results for the three and nine months ended February 28, 2015. For the three months ended February 28, 2015, total sales decreased $55,545, or 1.8%, to $3,010,618 from $3,066,163 in the three months ended February 28, 2014. Net loss was $168,371, or $(0.06) per fully diluted share, for the three months ended February 28, 2015 as compared to net loss of $72,107, or $(0.02) per fully diluted share, for the three months ended February 28, 2014. For the nine months ended February 28, 2015, total sales increased $102,748, or 1.1%, to $9,211,410 from $9,108,662 in the nine months ended February 28, 2014. Net loss was $186,428, or $(0.06) per fully diluted share, for the nine months ended February 28, 2015 as compared to net loss of $381,867, or $(0.13) per fully diluted share, for the nine months ended February 28, 2014.

Balancer segment sales focus throughout the world on end-users, rebuilders and original equipment manufacturers of grinding machines with the target geographic markets of North America, Asia, Europe and South America. Balancer segment sales decreased $66,379, or 3.4%, to $1,903,482 for the three months ended February 28, 2015 compared to $1,969,861 for the three months ended February 28, 2014. The decrease is primarily attributed to softer sales in North America, offset in part by increased sales in Asia for the quarter.

Balancer segment sales decreased $171,098, or 2.9%, to $5,666,501 for the nine months ended February 28, 2015 compared to $5,837,599 for the nine months ended February 28, 2014. The decrease is primarily attributed to softer sales in North America, offset in part by increased sales in Asia for the first three quarters of the fiscal year.

The Measurement segment product line consists of laser-based surface measurement and laser-based distance measurement and dimensional sizing products and ultrasonic-based remote tank monitoring products. Total Measurement segment sales increased $10,834, or 1.0%, to $1,107,136 for the three months ended February 28, 2015 compared to $1,096,302 for the three months ended February 28, 2014, driven by an increase in revenues associated with the sales of remote tank monitoring products and related monitoring services, offset by decreased sales of laser-based surface measurement and laser-based distance measurement products.

Measurement segment sales increased $273,846, or 8.4%, to $3,544,909 for the nine months ended February 28, 2015 compared to $3,271,063 for the nine months ended February 28, 2014, driven by an increase in revenues associated with the sales of remote tank monitoring products and related monitoring services and an increase in sales of laser-based surface measurement products.

Gross margin for the three months ended February 28, 2015 decreased to 44.9% as compared to 47.5% for the three months ended February 28, 2014. Gross margin for the nine months ended February 28, 2015 increased to 47.4% as compared to 46.7% for the nine months ended February 28, 2014. The fluctuations in gross margin in both the three and nine month periods ended February 28, 2015 compared to the three and nine month periods in the prior fiscal year is primarily influenced by shifts in product sales mix involving our five product lines.

Operating expenses decreased $38,715, or 2.5%, to $1,500,870 for the three months ended February 28, 2015 as compared to $1,539,585 for the three months ended February 28, 2014. General, administrative and selling expenses increased $17,168, or 1.2%, for the three months ended February 28, 2015 as compared to the same period in the prior year due in part to increases in personnel expenses offset by reductions in professional fees and depreciation expense. Research and development expenses decreased $55,883, or 36.9%, for the quarter ended February 28, 2015 as compared to the same period in the prior year due to fewer development projects within our existing product lines occurring during the third quarter of Fiscal 2015 as compared to the third quarter of Fiscal 2014.  

Operating expenses decreased $100,876, or 2.2%, to $4,536,317 for the nine months ended February 28, 2015 as compared to $4,637,193 for the nine months ended February 28, 2014. General, administrative and selling expenses decreased $3,228, or 0.1%, for the nine months ended February 28, 2015 as compared to the same period in the prior year. Increases in personnel costs and marketing and trade show expenses were offset by decreases in professional fees, depreciation expense and other general office and utility costs. Research and development expenses decreased $97,648, or 25.0%, for the first three quarters of Fiscal 2015 as compared to the same period in the prior year due to fewer development projects within our existing product lines occurring during the first three quarters of Fiscal 2015 as compared to the same period of Fiscal 2014.  

"While our consolidated sales performance for the third quarter of Fiscal 2015 was consistent with prior quarters, the mix of products sold weighted more toward our lower margin products, which resulted in the net loss recorded for the quarter," commented James A. Fitzhenry, President and CEO of Schmitt Industries.

"We remain focused on executing on our sales strategies across our product lines and are encouraged by the development of our Xact® product line, which continues to record quarter-over-quarter growth, and we note that sales of SBS products into Asia continue to show positive trends.  It is important to note that we are EBITDA positive for the fiscal year to date, and we are generating cash from operations.  We expect our fourth quarter to show sales growth and profitability and we are working to close out our fiscal year on a profitable basis," Fitzhenry concluded.

About Schmitt Industries

Schmitt Industries, Inc. (the Company) designs, manufactures and sells high precision test and measurement products for two main business segments: the Balancer Segment and the Measurement Segment. For the Balancer Segment, the Company designs, manufactures and sells computer-controlled vibration detection, balancing and process control systems for the worldwide machine tool industry, particularly for grinding machines. For the Measurement Segment, the Company designs, manufactures and sells laser and white light sensors for distance, dimensional and area measurement for a wide variety of commercial applications, laser-based microroughness measurement products for the semiconductor wafer and hard disk drive industries and for other industrial applications, laser-based surface analysis and measurement products for a variety of scientific applications, and ultrasonic measurement products that accurately measure the liquid levels of propane and diesel tanks and transmit that data via satellite to a secure web site for display. The Company also provides sales and service for Europe and parts of Asia through its wholly owned subsidiary, Schmitt Europe Limited (SEL), located in Coventry, England and through its sales representative office located in Shanghai, China. 

FORWARD-LOOKING STATEMENTS

Certain statements in this release, including but not limited to remarks by James A. Fitzhenry, are "forward-looking statements." These statements are based upon current expectations, estimates and projections about the Company's business that are based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including, but not limited to, general economic conditions and global financial concerns, the volatility of the Company's primary markets, efforts to accelerate growth in sales of the Xact® tank monitoring systems and the ability to satisfy expected demand, the ability to develop new products to satisfy changes in consumer demands, the intensity of competition, the effect on production time and overall costs of products if any of our primary suppliers are lost or if a primary supplier increases the prices of raw materials or components, the ability to ramp up manufacturing to satisfy increasing demand, maintenance of a significant investment in inventories in anticipation of future sales, existing cash and credit facilities level which may not be sufficient to fund future growth, fluctuations in quarterly and annual operating results, attracting and retaining key management and qualified technical and sales personnel, changes in effective tax rates, the ability to reduce operating costs if sales decline, increased costs due to changes in securities laws and regulations, protection of intellectual property rights, and risks from international sales and currency fluctuations.

For further information regarding risks and uncertainties associated with the Company's business, please refer to Schmitt's SEC filings, including, but not limited to, its Forms 10-K, 10-Q and 8-K.

The forward-looking statements in this release speak only as of the date on which they were made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release, or for changes to this document made by wire services or internet service providers.

SCHMITT INDUSTRIES, INC.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
 
  February 28, 2015 May 31,
2014
ASSETS    
Current assets    
Cash and cash equivalents  $ 1,652,564  $ 1,510,565
Accounts receivable, net  2,453,944  2,235,194
Inventories  4,716,335  4,789,822
Prepaid expenses  165,617  152,237
Income taxes receivable  1,529  1,339
   8,989,989  8,689,157
     
Property and equipment, net  1,099,892  1,191,591
     
Other assets     
Intangible assets, net  852,294  943,643
TOTAL ASSETS  $ 10,942,175  $ 10,824,391
     
LIABILITIES & STOCKHOLDERS' EQUITY    
Current liabilities    
Accounts payable  $ 602,745  $ 512,219
Accrued commissions  242,565  204,772
Accrued payroll liabilities  134,306  127,035
Other accrued liabilities  601,115  366,848
Income taxes payable  --   210
Total current liabilities   1,580,731  1,211,084
     
Stockholders' equity    
Common stock, no par value, 20,000,000 shares authorized, 2,995,910 shares issued and outstanding at February 28, 2015 and May 31, 2014  10,488,463  10,438,750
Accumulated other comprehensive loss  (378,485)  (263,337)
Accumulated deficit  (748,534)  (562,106)
Total stockholders' equity  9,361,444  9,613,307
     
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY  $ 10,942,175  $ 10,824,391
 
SCHMITT INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED FEBRUARY 28, 2015 AND 2014
(UNAUDITED)
 
  Three Months Ended February 28, Nine Months Ended February 28,
  2015 2014 2015 2014
         
Net sales  $ 3,010,618  $ 3,066,163  $ 9,211,410  $ 9,108,662
Cost of sales  1,660,256  1,608,233  4,843,303  4,851,742
Gross profit  1,350,362  1,457,930  4,368,107  4,256,920
         
Operating expenses:        
General, administration and sales  1,405,140  1,387,972  4,243,492  4,246,720
Research and development  95,730  151,613  292,825  390,473
Total operating expenses  1,500,870  1,539,585  4,536,317  4,637,193
         
Operating loss  (150,508)  (81,655)  (168,210)  (380,273)
         
Other income (loss)  (15,578)  11,497  (11,181)  5,404
         
Loss before income taxes  (166,086)  (70,158)  (179,391)  (374,869)
         
Provision for income taxes  2,285  1,949  7,037  6,998
         
Net loss  $ (168,371)  $ (72,107)  $ (186,428)  $ (381,867)
         
Net loss per common share, basic  $ (0.06)  $ (0.02)  $ (0.06)  $ (0.13)
         
Weighted average number of common shares, basic  2,995,910  2,990,910  2,995,910  2,990,910
         
Net loss per common share, diluted  $ (0.06)  $ (0.02)  $ (0.06)  $ (0.13)
         
Weighted average number of common shares, diluted  2,995,910  2,990,910  2,995,910  2,990,910

For more information contact: Ann M. Ferguson, CFO and Treasurer (503) 227-7908 or visit our web site at www.schmitt-ind.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ribo Advances Lipid Disorder Strategy with SR122 Trial

Updated Category News Views 114

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?

Updated Category News Views 65

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Continue Reading
Burtch Works Joins Databricks: Fueling AI Success

Updated Category News Views 20

Game-Changer for AI Talent Market First off, let me tell you, in this data-driven world, finding solid AI talent is like hitting the jackpot. Burtch Works teaming up with Databricks? That's like leaping into a goldmine fully prepared. We're talking about forward-deployed engineers and specialized AI talent coming straight to your door. Closing the Impossible Talent Gap...

Continue Reading
Bimbo Bakeries Teamsters Gear Up for Strike in NJ

Updated Category News Views 102

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Continue Reading
Zura Bio Faces Tough Road After Trial Failure

Updated Category News Views 155

Investor Dilemma: ZURA Takes a Nosedive November 9, 2026, wasn't a day to remember for anyone holding shares in Zura Bio. If ever there's a classic lesson in biotech investing's volatility, this is it: shares of Zura Biotech (NASDAQ:ZURA) cratered by about 72% after news broke that their much-hyped Phase 2 TibuSHIELD trial for tibulizumab hit the skids. For a company that...

Continue Reading
Gold.com Faces Fiduciary Investigation by Levi & Korsinsky

Updated Category News Views 56

Gold.com in Hot Water: What Shareholders Need to Know You ever wonder how firms like Gold.com find themselves in sticky situations before the ink's dry on the quarterly report? Well, strap in because Levi & Korsinsky, LLP is poking around to see if some officers and directors over there have taken a stroll down Breach Avenue. And let me tell you, if you're holding onto...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 115

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 126

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Mesh Security Bolsters Team with Five Cybersecurity Experts

Updated Category News Views 252

New Blood in Cybersecurity: Mesh's Strategic Moves Ever felt like the cybersecurity world is in a constant game of catch-up? You're not wrong. In today's digital battleground, companies don't just need more tools—they need collective wisdom to bind it all together. And it seems like Mesh Security just caught onto that notion, stacking their deck with five new...

Continue Reading
Charitable Giving Turbocharges E-commerce Conversion Rates

Updated Category News Views 50

Charitable Giving: The Secret Sauce for E-commerce Success In an e-commerce arena teeming with bland sameness, charitable giving is proving to be a game-changing hook. That's right—brands partnering with Change and DailyKarma have found a magic formula where customers flourish and causes benefit. With over $7.4 million in donations spread across more than 3 million...

Continue Reading

Top 5 Most Recently Viewed Articles

Get A Drip Names New CMO Amid Longevity Boom

Updated Category News Views 21

So, here's a curveball in the health gig—longevity's caught a second wind. And who's riding the wave? Get A Drip, the UK hotshot in the wellness league. They've just snagged Dr. Luke Pratsides as their new Chief Medical Officer. Imagine adding a sharp arrow to the quiver at a time when folks are head-over-heels for living longer and staying healthier. Longevity at the...

Continue Reading
Class Action Lawsuit Alert for Marex Group Investors - Act Now!

Updated Category News Views 157

Attention Investors: Marex Group Class Action Lawsuit Announced Investors in Marex Group plc (NASDAQ: MRX) should take note of an important development. A class action lawsuit has been initiated against Marex on behalf of those who purchased shares during the specified time frame. This legal action addresses serious allegations of financial misconduct, leading to...

Continue Reading
Navigating Political Challenges: Macron's Strategy with Barnier

Updated Category News Views 69

Understanding Barnier's New Role in French Politics After navigating the intricate Brexit negotiations, Michel Barnier has now stepped into a demanding role as Prime Minister. This position is crucial for tackling the urgent challenges within France's divided political environment. Challenges Awaiting Barnier Emmanuel Macron selected Barnier to steer his government...

Continue Reading
Verona Pharma Receives Shareholder Approval for Merck Deal

Updated Category News Views 211

Verona Pharma's Shareholders Greenlight Merck Acquisition In a significant step for Verona Pharma, shareholders have given the green light for the proposed acquisition by Merck & Co., marking a pivotal moment in the biopharmaceutical company's journey. Verona Pharma plc, listed on Nasdaq under the ticker VRNA, focuses on developing innovative therapies for chronic...

Continue Reading
2024 Luxury Resale Insights from The RealReal

Updated Category News Views 818

Insights from The RealReal's 2024 Luxury Resale Report Consumers Lead the Charge, Redefining Trends and Investing in Lasting Value The RealReal, the largest online marketplace for authenticated resale luxury goods, has unveiled its seventh annual 2024 Luxury Resale Report. This extensive report draws on 13 years of data to analyze the current state of luxury resale,...

Continue Reading